Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Sorrento Therapeutics (SRNE) Could Be THE Most Disruptive Company In Cancer R&D

|Includes: Sorrento Therapeutics, Inc. (SRNE)

Please see article and (two great videos!) on Sorrento Therapeutics (NASDAQ:SRNE) at my new site MicrocapResearch.com

Gary

Disclosure: The author is long SRNE.